Evidence map›Paper›PMID 40507918›Full record

ArticleInternational journal of molecular sciences2025

Novel lncRNA

Klaudia Samorowska, Elżbieta Wanowska, Michał Wojciech Szcześniak

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Klaudia SamorowskaFaculty of Biology, Institute of Human Biology and Evolution, Adam Mickiewicz University in Poznan, Uniwersytetu Poznańskiego 6, 61-614 Poznań, Poland.
Elżbieta WanowskaFaculty of Biology, Institute of Human Biology and Evolution, Adam Mickiewicz University in Poznan, Uniwersytetu Poznańskiego 6, 61-614 Poznań, Poland.ORCID 0000-0001-7179-1805
Michał Wojciech SzcześniakFaculty of Biology, Institute of Human Biology and Evolution, Adam Mickiewicz University in Poznan, Uniwersytetu Poznańskiego 6, 61-614 Poznań, Poland.ORCID 0000-0002-6050-9525

Funding

UAM Initiative of Excellence - Research University project 037/02/POB2/0008UAM Initiative of Excellence - Research University project 054/13/SNP/0012
6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are transcripts over 200 nucleotides long that do not encode proteins. Although many lncRNAs remain uncharacterized, they are known to play diverse regulatory roles in gene expression. A group of lncRNAs called natural antisense transcripts can form double-stranded structures with their sense partners due to sequence complementarity. These duplexes can become substrates for A-to-I RNA editing, an epitranscriptomic modification mediated by ADAR enzymes. RNA editing is known to influence transcript splicing, affect the resulting gene expression product or alter RNA stability, all of which can impact cancer cell biology. Here, we show a novel natural antisense transcript,

Indexed as

Breast NeoplasmsGene Expression Regulation, NeoplasticRNA, Long NoncodingCell Line, TumorCell ProliferationFemaleHumansMCF-7 CellsRNA, AntisenseRNA EditingRNA StabilityRNA, AntisenseRNA, Long NoncodingA-to-I RNA editingbreast cancerlncRNAnatural antisense transcript

Identifiers

PMID40507918
PMCPMC12155537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.